FindTrial
Sign In

Study on the Mechanism of PCN-based Microneedles promoting the burial and clearance of apoptotic fibroblasts for the Removal of Maxillofacial Hypertrophic Scars

Study on the Mechanism of PCN-based Microneedles promoting the burial and clearance of apoptotic fibroblasts for the Removal of Maxillofacial Hypertrophic Scars

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114869
Enrollment
Unknown
Registered
2025-12-18
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar

Interventions

Hypertrophic scar group:Hypertrophic scar tissue exists

Sponsors

Stomatological Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years, diagnosed with hypertrophic scars (disease course 6-24 months); 2. Has not received corticosteroid or laser treatment for at least 3 months; 3. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Keloids, scar malignant transformation, or other skin diseases; 2. History of pregnancy, immunodeficiency, or photosensitive disorders.

Design outcomes

Primary

MeasureTime frame
Hyperplasia index;—

Countries

China

Contacts

Public ContactMeixian Liu

Stomatological Hospital of Shanxi Medical University

liumx@sxmu.edu.cn+86 351 4690868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026